Smart Pills Technology Market to Reach $7.5 Bn, Globally, by 2030 at 8.8% CAGR: Allied Market Research

News provided by

Apr 21, 2022, 09:10 ET

Surge in the prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others drive the growth of the global smart pills technology market.

PORTLAND, Ore., April 21, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Smart Pills Technology Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), by Target Area (Esophagus, Stomach, Small Intestine, Large Intestine), by Disease Indication (Barrett'S Esophagus, Small Bowel Diseases, Colon Cancer, Others), by End User (Hospitals and Clinics, Diagnostic Centres, Research Centres): Global Opportunity Analysis and Industry Forecast, 2020-2030." According to the report, the global smart pills technology industry was estimated at $3.2 billion in 2020, and is expected to hit $7.5 billion by 2030, registering a CAGR of 8.8% from 2021 to 2030.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/707

Drivers, restraints, and opportunities-

Increase in chronic disorders such as cancer, diabetes, and others, and surge in the prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), gastric ulcers, and others drive the growth of the global smart pills technology market. On the other hand, high cost associated with the ingestible sensor impedes the growth to some extent. Nevertheless, rise in technological advances pertaining to the best smart pill is expected to create lucrative opportunities in the industry.

Covid-19 Scenario-

There was a significant decline in overall outpatient visits across the world, which impacted the global smart pills technology market negatively, especially during the initial period, since they are generally provided to patients in hospitals and healthcare centers.
However, as the global situation is getting better, the market is anticipated to get back on track soon.

The hospitals & clinics segment to retain the lion's share

By end-user, the hospitals & clinics segment held the major share in 2020, garnering nearly half of the global smart pills technology market, owing to surge in the number of patients suffering from colon cancer. The research centers segment, on the other hand, is projected to cite the fastest CAGR of 13.0% throughout the forecast period, due to increased R&D investments in developing smart pills.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/707

The Barrett'S Esophagus segment to dominate by 2030

By disease indication, the Barrett'S Esophagus segment contributed to the lion's share in 2020, holding nearly two-fifths of the global smart pills technology market, due to rise in the prevalence of gastrointestinal disorders among people. However, the colon cancer segment is projected to manifest the fastest CAGR of 9.7% from 2021 to 2030.

North America held the major share in 2020

By region, North America dominated in 2020, garnering around two-fifths of the global smart pills technology market. This is attributed to increase in technological advancements in the healthcare sector, rise in the prevalence of colorectal cancer, and regulatory approvals of new products across the region. The market across Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 10.2% throughout the forecast period. Developments in healthcare infrastructure coupled with the higher prevalence of chronic and targeted diseases such as cancer and others in the region drive the market growth.

Key players in the industry-

Proteus Digital Health
Olympus Corporations
RF Co., Ltd
HQ, Inc.
CapsoVision, Inc.
Medtronic Plc.
IntroMedic Co., Ltd
JINSHAN Science and Technology
Check Cap
Koninklijke Philips N.V

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Newborn Screening Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Urinalysis Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Gene Editing Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Intrauterine Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Myasthenia Gravis Treatment Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Graft Versus Host Disease Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Botulinum Toxin Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Computational Biology Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Gene Sequencing Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Rett Syndrome Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/